• Board meeting scheduled for May 23, 2026, to approve audited standalone and consolidated financial results for Q4 and year ended March 31, 2026.
• Trading window closed from April 1, 2026, to May 26, 2026, for directors, designated employees, and their family members.
• Disclosure made pursuant to SEBI Listing Obligations and Disclosure Requirements Regulation 29(1)(a).